Retrieved 23 March 2019
Topical calcineurin inhibitors are regarded as safe for short-term or intermittent long-term use, although they are generally less effective than corticosteroids
Which raises an obvious point: if a medication is changing your blood pressure, your glucose, your lipids, and your kidney markers, the person prescribing it should be the same person managing your blood pressure, glucose, lipids, and kidney function
I think there is considerable potential for this drug (and class) as a treatment for obstructive sleep apnea
Placebo: prdida media del 10,1% desde baseline, solo el 10,4% mantuvo el 80% del peso perdido
When Standard Doses Make Sense Acute injuries benefit from rapid, robust healing signals